Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postexposure Prophylaxis With Single Dose Doxycycline for the Prevention of Tick-borne Relapsing Fever

NCT06045481 is registered in ClinicalTrials.gov with Medical Corps, Israel Defense Force as lead sponsor.

NCT NCT06045481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06045481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postexposure Prophylaxis With Single Dose Doxycycline for the Prevention of Tick-borne Relapsing Fever
Lead sponsor
Medical Corps, Israel Defense Force
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2024
Completion date
October 31, 2027
Enrollment
526 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing fever, tick-borne